FTA threatens Korea to leap up for new drug R&D

The KPMA sensitively worries that the guarantee of patent issues under the KORUS FTA agreement might cause local drug industries to lose a leap-up chance for lifting Korea to the nations of new drug development.

The industry strongly urged to the government in the process of the KORUS FTA talks that extraordinary protective requests by the U. S. side for the intellectual property rights sh...